Restricted Time Win Ratio: From Estimands to Estimation

Tuo Wang Speaker
Eli Lilly and Company
 
Wednesday, Aug 6: 9:35 AM - 9:55 AM
Topic-Contributed Paper Session 
Music City Center 
The win ratio is a novel approach to analyzing prioritized composite endpoints in clinical trials. The win ratio has grown increasingly popular and has been applied in many ongoing cardiovascular clinical trials. Despite the intuitive interpretation of win ratio statistics, the traditionally used win ratio estimands are heavily influenced by the pattern of censoring. Treating missing values or censored data as ties is generally not a reliable way of handling missing values even in the estimation procedure. To avoid this complication, we propose the restricted time win ratio, which is the win ratio at a pre-specified time point and can be written in terms of the expectations of potential outcomes. To estimate the proposed estimand, we develop an approximately fully conditional specification algorithm which imputes the missing data of longitudinal and clinical outcomes jointly up to the pre-specified time point. The imputation algorithm can be easily revised to adjust a different hierarchical structure of the sequential comparisons specified by the users. Simulation studies in realistic settings show that the proposed imputation algorithm provides an unbiased and robust estimation of the restricted time win ratio. Finally, real data from a cardiovascular clinical trial are used to illustrate the proposed method.

Keywords

Win Ratio

Estimand

Hierarchical composite endpoint